Free Trial
→ Warning: “DOGE Collapse” imminent (From Altimetry) (Ad) Buy MET Stock  Free MET Stock Alerts

MetLife (MET) Financials

MetLife logo
$72.65 -0.30 (-0.41%)
Closing price 03:59 PM Eastern
Extended Trading
$71.30 -1.36 (-1.87%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for MetLife

Annual Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 5,215 747 3,907 4,982 5,721 5,191 6,654 5,099 1,380 4,226
Consolidated Net Income / (Loss)		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444
Net Income / (Loss) Continuing Operations		 4,061 3,588 5,006 5,128 5,909 5,418 6,876 5,302 1,602 4,444
Total Pre-Tax Income 		5,651 4,281 3,536 6,307 6,795 6,927 8,518 6,364 2,162 5,622
Total Revenue		 61,343 60,787 62,308 67,941 69,620 67,842 68,696 72,444 67,899 72,095
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 61,343 60,787 62,308 67,941 69,620 67,842 68,696 72,444 67,899 72,095
Other Service Charges		 7,497 7,168 6,851 7,382 7,445 7,452 7,863 7,855 7,678 7,575
Net Realized & Unrealized Capital Gains on Investments		 17,443 16,417 16,465 16,719 19,940 18,356 19,681 12,405 14,944 18,466
Premiums Earned		 36,403 37,202 38,992 43,840 42,235 42,034 41,152 48,510 44,283 44,945
Other Non-Interest Income		 - - - - - - - 3,674 994 1,109
Total Non-Interest Expense		 55,692 56,506 58,772 61,634 62,825 60,915 60,178 66,080 65,737 66,473
Property & Liability Insurance Claims		 39,559 41,534 43,920 46,669 47,925 46,675 48,517 53,401 52,450 53,067
Insurance Policy Acquisition Costs		 1,356 1,223 1,231 1,251 1,211 1,090 880 706 622 595
Other Operating Expenses		 14,777 13,749 13,621 13,714 13,689 13,150 12,018 11,973 12,665 12,811
Income Tax Expense		 1,590 693 -1,470 1,179 886 1,509 1,642 1,062 560 1,178
Preferred Stock Dividends Declared		 158 103 103 141 178 216 201 185 198 200
Net Income / (Loss) Attributable to Noncontrolling Interest		 12 4.00 10 5.00 10 11 21 18 24 18
Basic Earnings per Share		 $4.67 $0.68 $3.65 $4.95 $6.10 $5.72 $7.71 $6.35 $1.82 $5.98
Weighted Average Basic Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Diluted Earnings per Share		 $4.62 $0.67 $3.62 $4.91 $6.06 $5.68 $7.65 $6.30 $1.81 $5.94
Weighted Average Diluted Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Weighted Average Basic & Diluted Shares Outstanding		 1.12B 1.10B 1.07B 1.01B 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Cash Dividends to Common per Share		 $1.48 $1.58 $1.60 $1.66 $1.74 $1.82 $1.90 $1.98 $2.06 $2.16

Quarterly Income Statements for MetLife

This table shows MetLife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 1,098 1,549 14 370 422 574 800 912 1,275 1,239
Consolidated Net Income / (Loss)		 1,167 1,581 85 408 495 614 875 953 1,341 1,275
Net Income / (Loss) Continuing Operations		 1,167 1,581 85 408 495 614 875 953 1,341 1,275
Total Pre-Tax Income 		1,415 2,026 257 430 534 941 1,045 1,202 1,994 1,381
Total Revenue		 22,283 17,842 15,200 16,623 15,866 20,210 16,751 17,823 17,909 19,612
Total Non-Interest Income		 22,283 17,842 15,200 16,623 15,866 20,210 16,751 17,823 17,909 19,612
Other Service Charges		 2,003 1,893 1,928 1,909 1,940 1,901 1,922 1,919 1,876 1,858
Net Realized & Unrealized Capital Gains on Investments		 2,948 4,710 3,871 3,036 2,696 5,341 4,082 4,276 5,917 4,191
Premiums Earned		 17,332 9,005 9,589 11,678 11,230 11,786 10,053 11,628 10,647 12,617
Total Non-Interest Expense		 20,868 15,816 14,943 16,193 15,332 19,269 15,706 16,621 15,915 18,231
Property & Liability Insurance Claims		 18,753 10,706 11,736 13,726 12,771 14,217 12,364 13,475 12,634 14,594
Insurance Policy Acquisition Costs		 158 155 159 151 153 159 147 148 150 150
Other Operating Expenses		 2,922 3,233 3,048 3,133 3,204 3,280 3,195 3,180 3,131 3,305
Income Tax Expense		 248 445 172 22 39 327 170 249 653 106
Preferred Stock Dividends Declared		 64 29 66 32 67 33 67 34 67 32
Net Income / (Loss) Attributable to Noncontrolling Interest		 5.00 3.00 5.00 6.00 6.00 7.00 8.00 7.00 -1.00 4.00
Basic Earnings per Share		 $1.38 $1.97 $0.02 $0.48 $0.56 $0.76 $1.11 $1.28 $1.82 $1.77
Weighted Average Basic Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M
Diluted Earnings per Share		 $1.37 $1.96 $0.02 $0.48 $0.56 $0.75 $1.10 $1.28 $1.81 $1.75
Weighted Average Diluted Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M
Weighted Average Basic & Diluted Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M

Annual Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 1,944 5,125 -5,176 3,120 777 3,962 -444 79 444 -571
Net Cash From Operating Activities		 14,052 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598
Net Cash From Continuing Operating Activities		 14,052 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598
Net Income / (Loss) Continuing Operations		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444
Consolidated Net Income / (Loss)		 5,385 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444
Depreciation Expense		 693 652 795 628 630 619 694 673 718 714
Amortization Expense		 -1,141 -1,110 -1,044 -1,013 -999 -816 -874 -992 -1,332 -1,512
Non-Cash Adjustments to Reconcile Net Income		 -2,511 6,545 2,903 -1,209 821 1,565 1,321 2,615 10,627 8,804
Changes in Operating Assets and Liabilities, net		 11,626 7,833 5,609 8,204 7,425 4,853 4,330 5,446 2,106 2,148
Net Cash From Investing Activities		 -10,398 -5,850 -16,876 -5,634 -17,586 -18,569 -11,187 -2,620 -10,246 -11,493
Net Cash From Continuing Investing Activities		 -10,398 -5,850 -16,876 -5,634 -17,586 -18,569 -11,187 -2,620 -10,246 -11,493
Acquisitions		 -4,211 -6,963 -8,696 -4,173 -3,749 -4,247 -7,990 -7,793 -5,662 -3,981
Purchase of Investment Securities		 -173,918 -170,240 -124,533 -125,288 -108,884 -123,132 -141,348 -116,549 -89,164 -88,213
Divestitures		 0.00 156 - - 0.00 0.00 3,270 590 0.00 0.00
Sale and/or Maturity of Investments		 165,977 167,244 111,872 119,709 92,700 104,139 131,663 117,394 82,514 79,848
Other Investing Activities, net		 1,754 3,953 4,481 4,118 2,347 4,671 3,218 3,738 2,066 853
Net Cash From Financing Activities		 -1,218 -3,497 -906 -2,801 4,568 10,729 -1,126 -9,948 -2,940 -3,131
Net Cash From Continuing Financing Activities		 -1,218 -3,497 -906 -2,801 4,568 10,729 -1,126 -9,948 -2,940 -3,131
Issuance of Debt		 5,437 -3,636 4,560 224 3,526 4,812 1,912 -9,717 -612 1,609
Repayment of Debt		 -96,116 -84,610 -89,197 -90,814 -86,571 -85,498 -93,791 -98,726 -92,835 -97,749
Repurchase of Common Equity		 -1,930 -372 -2,927 -3,992 -2,285 -1,151 -4,303 -3,326 -3,103 -3,207
Payment of Dividends		 -1,769 -1,839 -1,820 -1,819 -1,821 -1,859 -1,842 -1,783 -1,764 -1,727
Other Financing Activities, Net		 93,179 86,960 88,478 92,326 91,719 93,467 97,398 103,604 95,374 97,943
Effect of Exchange Rate Changes		 -492 -302 - -183 9.00 163 -478 -397 -91 -545
Cash Interest Paid		 1,178 1,202 1,118 1,130 964 891 914 905 989 1,037
Cash Income Taxes Paid		 1,127 672 1,530 1,935 1,099 787 1,102 1,056 1,833 1,600

Quarterly Cash Flow Statements for MetLife

This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 -2,658 8,738 -3,765 -6,077 -3,980 14,266 -3,127 -2,544 -3,190 8,290
Net Cash From Operating Activities		 4,310 2,301 2,026 3,038 3,475 5,182 2,328 3,490 4,169 4,611
Net Cash From Continuing Operating Activities		 - 13,044 0.00 - - 13,721 0.00 - - 14,598
Net Income / (Loss) Continuing Operations		 - 5,302 0.00 - - 1,602 0.00 - - 4,444
Net Cash From Investing Activities		 -4,112 -197 -1,504 -6,346 -2,972 576 -2,627 -1,340 -2,162 -5,364
Net Cash From Continuing Investing Activities		 -4,112 -197 -1,504 -6,346 -2,972 576 -2,627 -1,340 -2,162 -5,364
Acquisitions		 -1,550 -1,725 -1,546 -1,196 -1,474 -1,446 -1,052 -1,209 -522 -1,198
Purchase of Investment Securities		 -26,038 -28,175 -24,822 -25,183 -22,075 -17,084 -19,739 -22,704 -21,965 -23,805
Sale and/or Maturity of Investments		 22,901 28,316 23,907 20,677 20,007 17,923 17,941 22,268 19,585 20,054
Other Investing Activities, net		 575 1,387 957 -644 570 1,183 223 305 740 -415
Net Cash From Financing Activities		 1,743 -4,468 -2,295 379 -848 -176 -261 -1,205 -1,146 -519
Net Cash From Continuing Financing Activities		 1,743 -4,468 -2,295 379 -848 -176 -261 -1,205 -1,146 -519
Issuance of Debt		 2,214 -4,128 -66 -629 111 -28 850 897 -447 309
Repayment of Debt		 -26,999 -18,933 -27,909 -22,827 -21,915 -20,184 -23,845 -26,462 -24,455 -22,987
Repurchase of Common Equity		 -674 -596 -780 -672 -792 -859 -1,172 -855 -774 -406
Payment of Dividends		 -464 -422 -455 -431 -459 -419 -444 -423 -450 -410
Other Financing Activities, Net		 27,666 19,611 26,915 24,938 22,207 21,314 24,350 25,638 24,980 22,975
Effect of Exchange Rate Changes		 -289 359 34 -110 -160 145 -239 1.00 118 -425
Cash Interest Paid		 156 314 183 289 206 311 231 296 223 287
Cash Income Taxes Paid		 35 444 171 945 236 481 130 864 279 327

Annual Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 877,933 898,764 719,892 687,538 740,463 795,146 759,708 663,072 687,584 677,457
Cash and Due from Banks		 12,752 12,651 12,701 15,821 16,598 19,795 20,047 20,195 20,639 20,068
Trading Account Securities		 369,747 306,380 328,189 312,321 342,264 354,809 353,685 288,132 292,500 292,427
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,988 3,308 3,524 3,582 3,523 17,786 3,185 3,446 3,589 3,489
Mortgage Servicing Rights		 67,102 65,167 68,731 75,752 80,529 83,919 79,353 83,763 92,506 89,012
Unearned Premiums Asset		 22,702 15,445 18,423 19,644 20,443 17,870 17,149 17,364 28,971 29,761
Deferred Acquisition Cost		 24,130 17,590 18,419 18,895 17,833 16,389 16,061 19,653 20,151 19,627
Separate Account Business Assets		 301,598 195,578 205,001 175,556 188,445 199,970 179,873 146,038 144,634 139,504
Goodwill		 9,477 9,220 9,590 9,422 9,308 10,112 9,535 9,297 9,236 8,901
Other Assets		 66,437 273,425 55,314 56,545 61,520 74,496 80,820 75,184 75,358 74,668
Total Liabilities & Shareholders' Equity		 877,933 898,764 719,892 687,538 740,463 795,146 759,708 663,072 687,584 677,457
Total Liabilities		 809,437 831,062 661,022 634,580 674,081 720,329 691,959 632,947 657,331 649,754
Short-Term Debt		 36,971 26,115 26,511 25,503 40,809 29,997 32,261 35,759 17,643 32,679
Long-Term Debt		 25,356 20,884 19,951 17,036 4,143 18,601 17,855 3,874 19,346 3,640
Future Policy Benefits		 191,879 166,636 177,974 186,780 194,909 206,656 199,721 187,222 196,406 193,646
Participating Policy Holder Equity		 219,480 188,515 200,836 201,327 212,499 225,833 223,384 229,408 219,655 240,729
Separate Account Business Liabilities		 301,598 195,578 205,001 175,556 188,445 199,970 179,873 146,038 144,634 139,504
Other Long-Term Liabilities		 34,153 233,334 30,749 28,378 33,276 39,272 38,865 30,646 59,647 39,556
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 68,419 67,702 58,870 52,958 66,382 74,817 67,749 30,125 30,253 27,703
Total Preferred & Common Equity		 67,949 67,531 58,676 52,741 66,144 74,558 67,482 29,881 30,015 27,445
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 67,949 67,531 58,676 52,741 66,144 74,558 67,482 29,881 30,015 27,445
Common Stock		 30,761 30,956 31,123 32,486 32,692 33,824 33,523 33,628 33,702 33,803
Retained Earnings		 35,519 34,683 26,527 28,926 33,078 36,491 41,197 40,332 40,146 42,626
Treasury Stock		 -3,102 -3,474 -6,401 -10,393 -12,678 -13,829 -18,157 -21,458 -24,591 -27,798
Accumulated Other Comprehensive Income / (Loss)		 4,771 5,366 7,427 1,722 13,052 18,072 10,919 -22,621 -19,242 -21,186
Noncontrolling Interest		 470 171 194 217 238 259 267 244 238 258

Quarterly Balance Sheets for MetLife

This table presents MetLife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets		 650,104 663,072 674,266 677,279 652,120 687,584 677,576 675,745 704,976 677,457
Cash and Due from Banks		 22,200 20,195 18,456 15,417 14,912 20,639 19,840 20,786 21,765 20,068
Trading Account Securities		 280,692 288,132 295,612 294,830 281,404 292,500 289,472 288,596 293,779 292,427
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 3,355 3,446 3,554 3,505 3,704 3,589 3,636 3,657 13,757 3,489
Mortgage Servicing Rights		 82,437 83,763 85,572 92,986 92,230 92,506 91,458 89,802 90,415 89,012
Unearned Premiums Asset		 17,666 17,364 18,692 18,530 19,002 28,971 29,986 31,820 31,443 29,761
Deferred Acquisition Cost		 21,523 19,653 19,976 19,850 19,737 20,151 19,842 19,568 20,401 19,627
Separate Account Business Assets		 135,771 146,038 148,417 145,946 135,624 144,634 141,003 139,707 148,809 139,504
Goodwill		 9,005 9,297 9,379 9,261 9,109 9,236 9,037 8,950 9,155 8,901
Other Assets		 77,455 75,184 74,608 76,954 76,398 75,358 73,302 72,859 75,452 74,668
Total Liabilities & Shareholders' Equity		 650,104 663,072 674,266 677,279 652,120 687,584 677,576 675,745 704,976 677,457
Total Liabilities		 624,774 632,947 641,843 646,787 626,225 657,331 648,780 648,205 673,812 649,754
Short-Term Debt		 25,073 35,759 34,653 33,545 33,492 17,643 33,569 18,109 17,536 32,679
Long-Term Debt		 18,407 3,874 3,863 3,835 3,811 19,346 3,752 18,527 18,970 3,640
Future Policy Benefits		 199,671 187,222 191,741 190,474 181,755 196,406 191,013 190,993 201,340 193,646
Participating Policy Holder Equity		 218,171 229,408 232,523 234,421 233,979 219,655 239,744 239,287 244,922 240,729
Separate Account Business Liabilities		 135,771 146,038 148,417 145,946 135,624 144,634 141,003 139,707 148,809 139,504
Other Long-Term Liabilities		 27,681 30,646 30,646 38,566 37,564 59,647 39,699 41,582 42,235 39,556
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 25,330 30,125 32,423 30,492 25,895 30,253 28,796 27,540 31,164 27,703
Total Preferred & Common Equity		 25,076 29,881 32,194 30,261 25,658 30,015 28,535 27,252 30,885 27,445
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 25,076 29,881 32,194 30,261 25,658 30,015 28,535 27,252 30,885 27,445
Common Stock		 33,601 33,628 33,629 33,642 33,678 33,702 33,730 33,752 33,778 33,803
Retained Earnings		 41,032 40,332 39,957 39,928 39,958 40,146 40,350 40,873 41,765 42,626
Treasury Stock		 -20,862 -21,458 -22,245 -22,923 -23,724 -24,591 -25,774 -26,637 -27,418 -27,798
Accumulated Other Comprehensive Income / (Loss)		 -28,695 -22,621 -19,147 -20,386 -24,254 -19,242 -19,771 -20,736 -17,240 -21,186
Noncontrolling Interest		 254 244 229 231 237 238 261 288 279 258

Annual Metrics and Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -16.33% -0.91% 2.50% 9.04% 2.47% -2.55% 1.26% 5.46% -6.27% 6.18%
EBITDA Growth		 -41.58% -26.52% -14.02% 80.16% 8.51% 4.73% 23.89% -27.50% -74.39% 211.63%
EBIT Growth		 -35.81% -24.24% -17.40% 78.37% 7.74% 1.94% 22.97% -25.29% -66.03% 160.04%
NOPAT Growth		 -35.94% -11.65% 39.52% 2.44% 15.23% -8.31% 26.91% -22.89% -69.79% 177.40%
Net Income Growth		 -15.01% -84.14% 370.73% 27.56% 15.23% -8.31% 26.91% -22.89% -69.79% 177.40%
EPS Growth		 -15.01% -84.14% 440.30% 35.64% 23.42% -6.27% 34.68% -17.65% -71.27% 228.18%
Operating Cash Flow Growth		 -14.19% 5.14% -16.86% -4.44% 17.45% -15.57% 6.08% 5.65% 5.19% 6.39%
Free Cash Flow Firm Growth		 186.02% 294.36% -27.07% 4.09% -166.35% 32.89% 286.49% 329.82% -92.29% 86.11%
Invested Capital Growth		 -0.71% -12.32% -8.17% -9.34% 16.58% 10.85% -4.50% -40.82% -3.61% -4.79%
Revenue Q/Q Growth		 -14.83% 4.88% 7.93% -0.26% 2.17% 3.47% -2.43% 0.19% 3.61% -0.82%
EBITDA Q/Q Growth		 -38.14% 15.43% 14.93% 23.45% -30.93% 0.06% 19.39% 0.15% -52.33% -6.91%
EBIT Q/Q Growth		 -32.81% 29.26% 23.64% 31.48% -26.96% 2.99% 21.96% 5.43% -33.42% 8.49%
NOPAT Q/Q Growth		 -32.40% 22.79% 70.39% -4.70% -19.96% -7.35% 24.52% 1.32% -37.64% 17.47%
Net Income Q/Q Growth		 -10.35% -77.50% 1,314.50% -4.70% -19.96% -7.35% 24.52% 1.32% -37.64% 17.47%
EPS Q/Q Growth		 -10.35% -77.50% 941.86% -7.53% -22.51% -6.89% 25.41% 3.96% -40.07% 20.24%
Operating Cash Flow Q/Q Growth		 -6.03% 8.19% -22.63% -6.00% 39.17% -0.24% -0.50% -17.62% 26.58% -3.76%
Free Cash Flow Firm Q/Q Growth		 177.20% 283.98% -67.69% 0.27% 14.83% 8.19% -13.92% -3.69% -49.66% 1,212.34%
Invested Capital Q/Q Growth		 -1.83% -21.92% -0.01% -0.32% -3.05% -3.54% -0.98% 1.38% 6.40% -5.39%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 8.48% 6.29% 5.28% 8.72% 9.23% 9.92% 12.14% 8.34% 2.28% 6.69%
EBIT Margin		 9.21% 7.04% 5.68% 9.28% 9.76% 10.21% 12.40% 8.78% 3.18% 7.80%
Profit (Net Income) Margin		 8.78% 1.40% 6.45% 7.55% 8.49% 7.99% 10.01% 7.32% 2.36% 6.16%
Tax Burden Percent		 95.29% 19.95% 113.69% 81.31% 86.96% 78.22% 80.72% 83.31% 74.10% 79.05%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 28.14% 16.19% -41.57% 18.69% 13.04% 21.78% 19.28% 16.69% 25.90% 20.95%
Return on Invested Capital (ROIC)		 3.09% 2.92% 4.55% 5.11% 5.71% 4.62% 5.70% 5.65% 2.34% 6.77%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.27% -2.08% 2.44% 5.11% 5.71% 4.62% 5.70% 5.65% 2.34% 6.77%
Return on Net Nonoperating Assets (RNNOA)		 4.54% -1.67% 1.80% 4.06% 4.19% 3.06% 3.95% 5.18% 2.97% 8.56%
Return on Equity (ROE)		 7.63% 1.25% 6.35% 9.17% 9.90% 7.67% 9.65% 10.83% 5.31% 15.34%
Cash Return on Invested Capital (CROIC)		 3.81% 16.06% 13.07% 14.90% -9.60% -5.68% 10.30% 56.93% 6.01% 11.68%
Operating Return on Assets (OROA)		 0.63% 0.48% 0.44% 0.90% 0.95% 0.90% 1.10% 0.89% 0.32% 0.82%
Return on Assets (ROA)		 0.61% 0.10% 0.50% 0.73% 0.83% 0.71% 0.88% 0.75% 0.24% 0.65%
Return on Common Equity (ROCE)		 7.57% 1.25% 6.33% 9.14% 9.87% 7.65% 9.61% 10.78% 5.26% 15.20%
Return on Equity Simple (ROE_SIMPLE)		 7.93% 1.26% 6.85% 9.72% 8.93% 7.27% 10.19% 17.74% 5.34% 16.19%
Net Operating Profit after Tax (NOPAT)		 4,061 3,588 5,006 5,128 5,909 5,418 6,876 5,302 1,602 4,444
NOPAT Margin		 6.62% 5.90% 8.03% 7.55% 8.49% 7.99% 10.01% 7.32% 2.36% 6.16%
Net Nonoperating Expense Percent (NNEP)		 -2.18% 5.00% 2.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 90.79% 92.96% 94.33% 90.72% 90.24% 89.79% 87.60% 91.22% 96.82% 92.20%
Earnings before Interest and Taxes (EBIT)		 5,651 4,281 3,536 6,307 6,795 6,927 8,518 6,364 2,162 5,622
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5,203 3,823 3,287 5,922 6,426 6,730 8,338 6,045 1,548 4,824
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.58 0.67 0.71 0.63 0.60 0.50 0.71 1.77 1.57 2.05
Price to Tangible Book Value (P/TBV)		 0.68 0.78 0.85 0.76 0.70 0.58 0.83 2.57 2.27 3.04
Price to Revenue (P/Rev)		 0.64 0.74 0.67 0.49 0.57 0.55 0.70 0.73 0.69 0.78
Price to Earnings (P/E)		 7.58 60.58 10.72 6.64 6.94 7.23 7.25 10.38 34.18 13.33
Dividend Yield		 4.15% 3.83% 3.70% 4.95% 4.03% 4.36% 3.32% 2.94% 3.23% 2.65%
Earnings Yield		 13.20% 1.65% 9.33% 15.06% 14.41% 13.83% 13.80% 9.64% 2.93% 7.50%
Enterprise Value to Invested Capital (EV/IC)		 0.69 0.70 0.72 0.63 0.61 0.54 0.67 1.04 0.95 1.14
Enterprise Value to Revenue (EV/Rev)		 1.46 1.31 1.22 0.88 0.98 0.98 1.14 1.00 0.94 1.01
Enterprise Value to EBITDA (EV/EBITDA)		 17.23 20.87 23.07 10.13 10.63 9.89 9.42 12.01 41.19 15.10
Enterprise Value to EBIT (EV/EBIT)		 15.86 18.63 21.44 9.51 10.05 9.61 9.22 11.41 29.49 12.96
Enterprise Value to NOPAT (EV/NOPAT)		 22.07 22.23 15.15 11.70 11.56 12.29 11.42 13.69 39.80 16.39
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.38 5.40 6.17 5.11 4.95 5.72 6.36 5.56 4.65 4.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.93 4.05 5.27 4.01 0.00 0.00 6.32 1.36 15.48 9.50
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.91 0.69 0.79 0.80 0.68 0.65 0.74 1.32 1.22 1.31
Long-Term Debt to Equity		 0.37 0.31 0.34 0.32 0.06 0.25 0.26 0.13 0.64 0.13
Financial Leverage		 0.86 0.80 0.74 0.80 0.73 0.66 0.69 0.92 1.27 1.26
Leverage Ratio		 12.61 13.05 12.79 12.59 11.97 10.88 10.91 14.54 22.37 23.55
Compound Leverage Factor		 12.61 13.05 12.79 12.59 11.97 10.88 10.91 14.54 22.37 23.55
Debt to Total Capital		 47.64% 40.98% 44.11% 44.54% 40.38% 39.38% 42.52% 56.82% 55.01% 56.73%
Short-Term Debt to Total Capital		 28.26% 22.77% 25.17% 26.71% 36.65% 24.31% 27.37% 51.26% 26.24% 51.04%
Long-Term Debt to Total Capital		 19.38% 18.21% 18.94% 17.84% 3.72% 15.07% 15.15% 5.55% 28.77% 5.69%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.42% 0.15% 0.18% 0.23% 0.21% 0.21% 0.23% 0.35% 0.35% 0.40%
Common Equity to Total Capital		 51.94% 58.88% 55.71% 55.23% 59.41% 60.41% 57.25% 42.84% 44.64% 42.87%
Debt to EBITDA		 11.98 12.29 14.14 7.18 7.00 7.22 6.01 6.56 23.89 7.53
Net Debt to EBITDA		 9.53 8.98 10.27 4.51 4.41 4.28 3.61 3.22 10.56 3.37
Long-Term Debt to EBITDA		 4.87 5.46 6.07 2.88 0.64 2.76 2.14 0.64 12.50 0.75
Debt to NOPAT		 15.35 13.10 9.28 8.30 7.61 8.97 7.29 7.48 23.09 8.17
Net Debt to NOPAT		 12.21 9.57 6.74 5.21 4.80 5.32 4.37 3.67 10.21 3.66
Long-Term Debt to NOPAT		 6.24 5.82 3.99 3.32 0.70 3.43 2.60 0.73 12.08 0.82
Noncontrolling Interest Sharing Ratio		 0.82% 0.53% 0.29% 0.37% 0.38% 0.35% 0.37% 0.52% 0.80% 0.86%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 4,998 19,710 14,375 14,963 -9,928 -6,663 12,426 53,409 4,118 7,664
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.07 0.07 0.08 0.10 0.10 0.09 0.09 0.10 0.10 0.11
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 130,823 114,701 105,332 95,497 111,334 123,415 117,865 69,758 67,242 64,022
Invested Capital Turnover		 0.47 0.50 0.57 0.68 0.67 0.58 0.57 0.77 0.99 1.10
Increase / (Decrease) in Invested Capital		 -937 -16,122 -9,369 -9,835 15,837 12,081 -5,550 -48,107 -2,516 -3,220
Enterprise Value (EV)		 89,626 79,773 75,822 60,008 68,300 66,593 78,544 72,586 63,755 72,843
Market Capitalization		 39,504 45,254 41,867 33,073 39,708 37,531 48,208 52,904 47,167 56,334
Book Value per Share		 $61.13 $61.44 $55.76 $53.44 $71.92 $82.85 $80.22 $38.08 $40.55 $39.64
Tangible Book Value per Share		 $52.60 $53.05 $46.65 $43.90 $61.80 $71.61 $68.89 $26.23 $28.07 $26.78
Total Capital		 130,823 114,701 105,332 95,497 111,334 123,415 117,865 69,758 67,242 64,022
Total Debt		 62,327 46,999 46,462 42,539 44,952 48,598 50,116 39,633 36,989 36,319
Total Long-Term Debt		 25,356 20,884 19,951 17,036 4,143 18,601 17,855 3,874 19,346 3,640
Net Debt		 49,575 34,348 33,761 26,718 28,354 28,803 30,069 19,438 16,350 16,251
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 -1,324 2,734 986 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 62,327 46,999 46,462 42,539 44,952 48,598 50,116 39,633 36,989 36,319
Total Depreciation and Amortization (D&A)		 -448 -458 -249 -385 -369 -197 -180 -319 -614 -798
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $6.10 $5.72 $7.36 $2.93 $1.82 $5.98
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $6.06 $5.68 $7.31 $2.91 $1.81 $5.94
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 915.83M 884.40M 825.08M 774.36M 723.02M 681.23M
Normalized Net Operating Profit after Tax (NOPAT)		 4,061 3,588 2,475 5,128 5,909 5,418 5,877 5,302 1,602 4,444
Normalized NOPAT Margin		 6.62% 5.90% 3.97% 7.55% 8.49% 7.99% 8.56% 7.32% 2.36% 6.16%
Pre Tax Income Margin		 9.21% 7.04% 5.68% 9.28% 9.76% 10.21% 12.40% 8.78% 3.18% 7.80%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 32.85% 215.34% 45.27% 35.47% 30.82% 34.31% 26.79% 33.63% 110.11% 38.86%
Augmented Payout Ratio		 68.69% 258.90% 118.08% 113.32% 69.49% 55.56% 89.37% 96.36% 303.81% 111.03%

Quarterly Metrics and Ratios for MetLife

This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 31.81% 0.77% -9.77% 7.43% -28.80% 13.27% 10.20% 7.22% 12.88% -2.96%
EBITDA Growth		 -30.71% 19.32% -86.72% -56.48% -62.26% -53.55% 306.61% 179.53% 273.41% 46.76%
EBIT Growth		 -30.71% 19.32% -86.72% -56.48% -62.26% -53.55% 306.61% 179.53% 273.41% 46.76%
NOPAT Growth		 -26.56% 4.56% -94.81% -55.41% -57.58% -61.16% 929.41% 133.58% 170.91% 107.65%
Net Income Growth		 -26.56% 4.56% -94.81% -55.41% -57.58% -61.16% 929.41% 133.58% 170.91% 107.65%
EPS Growth		 -22.60% 13.95% -98.94% -55.56% -59.12% -61.73% 5,400.00% 166.67% 223.21% 133.33%
Operating Cash Flow Growth		 22.93% -54.80% -0.69% -30.84% -19.37% 125.21% 14.91% 14.88% 19.97% -11.02%
Free Cash Flow Firm Growth		 389.33% 603.60% 156.22% -71.89% -88.12% -93.70% -82.17% -59.55% -151.27% 43.61%
Invested Capital Growth		 -42.19% -40.82% -30.99% -14.04% -8.16% -3.61% -6.80% -5.45% 7.08% -4.79%
Revenue Q/Q Growth		 44.00% -19.93% -14.81% 9.36% -4.55% 27.38% -13.72% 6.40% 0.48% 9.51%
EBITDA Q/Q Growth		 43.22% 43.18% -87.31% 67.32% 24.19% 76.22% 11.05% 15.02% 65.89% -30.74%
EBIT Q/Q Growth		 43.22% 43.18% -87.31% 67.32% 24.19% 76.22% 11.05% 15.02% 65.89% -30.74%
NOPAT Q/Q Growth		 27.54% 35.48% -94.62% 380.00% 21.32% 24.04% 42.51% 8.91% 40.71% -4.92%
Net Income Q/Q Growth		 27.54% 35.48% -94.62% 380.00% 21.32% 24.04% 42.51% 8.91% 40.71% -4.92%
EPS Q/Q Growth		 26.85% 43.07% -98.98% 2,300.00% 16.67% 33.93% 46.67% 16.36% 41.41% -3.31%
Operating Cash Flow Q/Q Growth		 -1.89% -46.61% -11.95% 49.95% 14.38% 49.12% -55.08% 49.91% 19.46% 10.60%
Free Cash Flow Firm Q/Q Growth		 25.69% -3.31% -35.71% -64.02% -46.86% -48.75% 82.01% -18.40% -167.35% 243.56%
Invested Capital Q/Q Growth		 -12.85% 1.38% 1.69% -4.32% -6.89% 6.40% -1.67% -2.94% 5.44% -5.39%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 6.35% 11.36% 1.69% 2.59% 3.37% 4.66% 6.24% 6.74% 11.13% 7.04%
EBIT Margin		 6.35% 11.36% 1.69% 2.59% 3.37% 4.66% 6.24% 6.74% 11.13% 7.04%
Profit (Net Income) Margin		 5.24% 8.86% 0.56% 2.45% 3.12% 3.04% 5.22% 5.35% 7.49% 6.50%
Tax Burden Percent		 82.47% 78.04% 33.07% 94.88% 92.70% 65.25% 83.73% 79.28% 67.25% 92.32%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 17.53% 21.96% 66.93% 5.12% 7.30% 34.75% 16.27% 20.72% 32.75% 7.68%
Return on Invested Capital (ROIC)		 4.03% 6.84% 0.46% 2.41% 3.10% 3.01% 5.29% 5.72% 8.32% 7.14%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.03% 6.84% 0.46% 2.41% 3.10% 3.01% 5.29% 5.72% 8.32% 7.14%
Return on Net Nonoperating Assets (RNNOA)		 3.97% 6.27% 0.46% 2.80% 4.88% 3.82% 6.56% 7.30% 10.76% 9.03%
Return on Equity (ROE)		 8.00% 13.12% 0.91% 5.20% 7.98% 6.83% 11.85% 13.02% 19.08% 16.17%
Cash Return on Invested Capital (CROIC)		 59.04% 56.93% 40.99% 19.51% 12.39% 6.01% 10.53% 10.05% -1.05% 11.68%
Operating Return on Assets (OROA)		 0.65% 1.16% 0.17% 0.28% 0.34% 0.47% 0.64% 0.70% 1.19% 0.74%
Return on Assets (ROA)		 0.54% 0.90% 0.06% 0.26% 0.31% 0.31% 0.54% 0.56% 0.80% 0.69%
Return on Common Equity (ROCE)		 7.96% 13.05% 0.91% 5.17% 7.91% 6.78% 11.76% 12.90% 18.91% 16.04%
Return on Equity Simple (ROE_SIMPLE)		 20.87% 0.00% 11.64% 10.71% 10.01% 0.00% 8.38% 10.78% 12.25% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,167 1,581 85 408 495 614 875 953 1,341 1,275
NOPAT Margin		 5.24% 8.86% 0.56% 2.45% 3.12% 3.04% 5.22% 5.35% 7.49% 6.50%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 93.65% 88.64% 98.31% 97.41% 96.63% 95.34% 93.76% 93.26% 88.87% 92.96%
Earnings before Interest and Taxes (EBIT)		 1,415 2,026 257 430 534 941 1,045 1,202 1,994 1,381
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,415 2,026 257 430 534 941 1,045 1,202 1,994 1,381
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.81 1.77 1.33 1.37 1.79 1.57 1.89 1.82 1.87 2.05
Price to Tangible Book Value (P/TBV)		 2.83 2.57 1.87 1.98 2.77 2.27 2.77 2.71 2.66 3.04
Price to Revenue (P/Rev)		 0.63 0.73 0.60 0.58 0.70 0.69 0.78 0.70 0.79 0.78
Price to Earnings (P/E)		 9.04 10.38 12.05 13.71 19.45 34.18 24.93 18.28 16.22 13.33
Dividend Yield		 3.44% 2.94% 3.63% 3.72% 3.35% 3.23% 2.85% 3.02% 2.58% 2.65%
Earnings Yield		 11.06% 9.64% 8.30% 7.29% 5.14% 2.93% 4.01% 5.47% 6.16% 7.50%
Enterprise Value to Invested Capital (EV/IC)		 0.97 1.04 0.89 0.94 1.08 0.95 1.09 1.02 1.08 1.14
Enterprise Value to Revenue (EV/Rev)		 0.93 1.00 0.89 0.89 1.04 0.94 1.03 0.93 1.00 1.01
Enterprise Value to EBITDA (EV/EBITDA)		 11.10 12.01 13.44 15.45 21.07 41.19 24.32 17.64 14.05 15.10
Enterprise Value to EBIT (EV/EBIT)		 11.10 11.41 13.44 15.45 21.07 29.49 24.32 17.64 14.05 12.96
Enterprise Value to NOPAT (EV/NOPAT)		 12.80 13.69 16.80 19.67 26.64 39.80 29.99 22.35 19.24 16.39
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.23 5.56 4.83 5.46 6.31 4.65 5.12 4.54 4.80 4.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 1.21 1.36 1.77 4.45 8.36 15.48 9.94 9.90 0.00 9.50
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.72 1.32 1.19 1.23 1.44 1.22 1.30 1.33 1.17 1.31
Long-Term Debt to Equity		 0.73 0.13 0.12 0.13 0.15 0.64 0.13 0.67 0.61 0.13
Financial Leverage		 0.98 0.92 1.00 1.16 1.58 1.27 1.24 1.28 1.29 1.26
Leverage Ratio		 14.91 14.54 16.14 19.75 25.42 22.37 22.08 23.32 23.78 23.55
Compound Leverage Factor		 14.91 14.54 16.14 19.75 25.42 22.37 22.08 23.32 23.78 23.55
Debt to Total Capital		 63.19% 56.82% 54.29% 55.07% 59.03% 55.01% 56.45% 57.09% 53.95% 56.73%
Short-Term Debt to Total Capital		 36.44% 51.26% 48.85% 49.42% 53.00% 26.24% 50.77% 28.22% 25.91% 51.04%
Long-Term Debt to Total Capital		 26.75% 5.55% 5.45% 5.65% 6.03% 28.77% 5.67% 28.87% 28.03% 5.69%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.37% 0.35% 0.32% 0.34% 0.38% 0.35% 0.39% 0.45% 0.41% 0.40%
Common Equity to Total Capital		 36.44% 42.84% 45.38% 44.59% 40.60% 44.64% 43.16% 42.46% 45.64% 42.87%
Debt to EBITDA		 7.20 6.56 8.22 9.06 11.49 23.89 12.65 9.84 7.04 7.53
Net Debt to EBITDA		 3.53 3.22 4.28 5.32 6.90 10.56 5.93 4.26 2.84 3.37
Long-Term Debt to EBITDA		 3.05 0.64 0.82 0.93 1.17 12.50 1.27 4.98 3.66 0.75
Debt to NOPAT		 8.31 7.48 10.28 11.53 14.52 23.09 15.60 12.47 9.65 8.17
Net Debt to NOPAT		 4.07 3.67 5.35 6.78 8.72 10.21 7.31 5.40 3.90 3.66
Long-Term Debt to NOPAT		 3.52 0.73 1.03 1.18 1.48 12.08 1.57 6.31 5.01 0.82
Noncontrolling Interest Sharing Ratio		 0.57% 0.52% 0.58% 0.73% 0.96% 0.80% 0.80% 0.89% 0.90% 0.86%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 51,389 49,688 31,945 11,493 6,107 3,130 5,697 4,649 -3,131 4,495
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.10 0.10 0.10 0.11 0.10 0.10 0.10 0.10 0.11 0.11
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 68,810 69,758 70,939 67,872 63,198 67,242 66,117 64,176 67,670 64,022
Invested Capital Turnover		 0.77 0.77 0.82 0.98 0.99 0.99 1.01 1.07 1.11 1.10
Increase / (Decrease) in Invested Capital		 -50,222 -48,107 -31,860 -11,085 -5,612 -2,516 -4,822 -3,696 4,472 -3,220
Enterprise Value (EV)		 67,000 72,586 62,959 63,762 68,428 63,755 71,737 65,651 72,783 72,843
Market Capitalization		 45,466 52,904 42,670 41,568 45,800 47,167 53,995 49,513 57,763 56,334
Book Value per Share		 $31.44 $38.08 $41.57 $39.51 $34.12 $40.55 $40.13 $38.32 $44.10 $39.64
Tangible Book Value per Share		 $20.15 $26.23 $29.46 $27.42 $22.01 $28.07 $27.42 $25.74 $31.03 $26.78
Total Capital		 68,810 69,758 70,939 67,872 63,198 67,242 66,117 64,176 67,670 64,022
Total Debt		 43,480 39,633 38,516 37,380 37,303 36,989 37,321 36,636 36,506 36,319
Total Long-Term Debt		 18,407 3,874 3,863 3,835 3,811 19,346 3,752 18,527 18,970 3,640
Net Debt		 21,280 19,438 20,060 21,963 22,391 16,350 17,481 15,850 14,741 16,251
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 43,480 39,633 38,516 37,380 37,303 36,989 37,321 36,636 36,506 36,319
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.42 $1.97 $0.02 $0.48 $0.56 $0.76 $1.11 $1.28 $1.82 $1.77
Adjusted Weighted Average Basic Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M
Adjusted Diluted Earnings per Share		 $0.41 $1.96 $0.02 $0.48 $0.56 $0.75 $1.10 $1.28 $1.81 $1.75
Adjusted Weighted Average Diluted Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 784.61M 774.36M 765.82M 752.02M 740.19M 723.02M 711.12M 700.32M 692.42M 681.23M
Normalized Net Operating Profit after Tax (NOPAT)		 371 1,581 180 -367 -243 614 875 809 1,341 1,275
Normalized NOPAT Margin		 1.67% 8.86% 1.18% -2.21% -1.53% 3.04% 5.22% 4.54% 7.49% 6.50%
Pre Tax Income Margin		 6.35% 11.36% 1.69% 2.59% 3.37% 4.66% 6.24% 6.74% 11.13% 7.04%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 34.30% 33.63% 47.44% 54.67% 68.78% 110.11% 73.29% 59.41% 45.89% 38.86%
Augmented Payout Ratio		 108.94% 96.36% 131.91% 138.66% 179.33% 303.81% 219.40% 184.64% 142.64% 111.03%

Frequently Asked Questions About MetLife's Financials

When does MetLife's financial year end?

According to the most recent income statement we have on file, MetLife's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MetLife's net income changed over the last 9 years?

In the past 9 years, MetLife's net income has ranged from $854 million in 2016 to $6.88 billion in 2021, and is currently $4.44 billion as of their latest financial filing in 2024.

How has MetLife revenue changed over the last 9 years?

Over the last 9 years, MetLife's total revenue changed from $61.34 billion in 2015 to $72.10 billion in 2024, a change of 17.5%.

How much debt does MetLife have?

MetLife's total liabilities were at $649.75 billion at the end of 2024, a 1.2% decrease from 2023, and a 19.7% decrease since 2015.

How much cash does MetLife have?

In the past 9 years, MetLife's cash and equivalents has ranged from $12.65 billion in 2016 to $20.64 billion in 2023, and is currently $20.07 billion as of their latest financial filing in 2024.

How has MetLife's book value per share changed over the last 9 years?

Over the last 9 years, MetLife's book value per share changed from 61.13 in 2015 to 39.64 in 2024, a change of -35.2%.

Remove Ads

Related Companies

This page (NYSE:MET) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored